590 related articles for article (PubMed ID: 1614411)
21. The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
Molero X; Miller LJ
Mol Pharmacol; 1991 Feb; 39(2):150-6. PubMed ID: 1899903
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
23. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
[TBL] [Abstract][Full Text] [Related]
25. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
Hunter JC; Suman-Chauhan N; Meecham KG; Dissanayake VU; Hill DR; Pritchard MC; Kneen CO; Horwell DC; Hughes J; Woodruff GN
Mol Pharmacol; 1993 Apr; 43(4):595-602. PubMed ID: 8474432
[TBL] [Abstract][Full Text] [Related]
26. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
[TBL] [Abstract][Full Text] [Related]
27. Discrimination between CCK receptors of guinea-pig and rat brain by cyclic CCK8 analogues.
Durieux C; Pham H; Charpentier B; Roques BP
Biochem Biophys Res Commun; 1988 Aug; 154(3):1301-7. PubMed ID: 3408499
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-resistant CCK analogs with high affinities for central receptors.
Charpentier B; Durieux C; Pelaprat D; Dor A; Reibaud M; Blanchard JC; Roques BP
Peptides; 1988; 9(4):835-41. PubMed ID: 3226959
[TBL] [Abstract][Full Text] [Related]
29. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas.
Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS
Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin antagonists.
Maton PN; Jensen RT; Gardner JD
Horm Metab Res; 1986 Jan; 18(1):2-9. PubMed ID: 2419234
[TBL] [Abstract][Full Text] [Related]
32. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
[TBL] [Abstract][Full Text] [Related]
33. Cyclic cholecystokinin analogues with high selectivity for central receptors.
Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand.
Van Dijk A; Richards JG; Trzeciak A; Gillessen D; Möhler H
J Neurosci; 1984 Apr; 4(4):1021-33. PubMed ID: 6325601
[TBL] [Abstract][Full Text] [Related]
35. [3H]SNF8702 autoradiography of CCK-B receptors in guinea pig brain and studies with a cloned rat CCK-B receptor.
Knapp RJ; Malatynska E; Hashimoto S; Fang S; Hunt M; Wamsley JK; Peterson P; Zalewska T; Hruby VJ; Yamamura HI
Ann N Y Acad Sci; 1994 Mar; 713():380-3. PubMed ID: 8185194
[No Abstract] [Full Text] [Related]
36. [3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors.
Durieux C; Corringer PJ; Bergeron F; Roques BP
Eur J Pharmacol; 1989 Sep; 168(2):269-70. PubMed ID: 2606153
[No Abstract] [Full Text] [Related]
37. Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes.
Rinken A; Harro J; Engström L; Oreland L
Biochem Pharmacol; 1998 Feb; 55(4):423-31. PubMed ID: 9514076
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex.
Durieux C; Coppey M; Zajac JM; Roques BP
Biochem Biophys Res Commun; 1986 Jun; 137(3):1167-73. PubMed ID: 3015138
[TBL] [Abstract][Full Text] [Related]
39. A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.
Mendre C; Rodriquez M; Gueudet C; Lignon MF; Galas MC; Laur J; Worms P; Martinez J
J Biol Chem; 1988 Aug; 263(22):10641-5. PubMed ID: 3392031
[TBL] [Abstract][Full Text] [Related]
40. [3H]-SR 27897B: a selective probe for autoradiographic labelling of CCK-A receptors in the brain.
Zajac JM; Gully D; Maffrand JP
J Recept Signal Transduct Res; 1996; 16(1-2):93-113. PubMed ID: 8771533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
